AA
APGE icon

ABC Arbitrage’s Apogee Therapeutics APGE Stock Holding History

ABC Arbitrage’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.02M Buy
+52,918
New +$4.77M 0.76% 30

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

ABC Arbitrage's APGE Position: Q2 2026 in Review

ABC Arbitrage opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 52,918 shares worth $7.02M. The stake represents 0.76% of the portfolio and ranks #30 among its holdings.

16 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • ABC Arbitrage held 52,918 shares of Apogee Therapeutics worth $7.02M as of Q2 2026.
  • Apogee Therapeutics was a new ABC Arbitrage position in Q2 2026.
  • Apogee Therapeutics made up 0.76% of ABC Arbitrage's portfolio in Q2 2026, its #30 holding.
  • 16 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.